Pandemic Monovalent (H5N1) Influenza Vaccine (Whole Virus Formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pandemic Monovalent (H5N1) Influenza Vaccine (Whole Virus Formulation), covering 2017-05-08 to 2017-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age [Phase 1]